ARS Pharmaceuticals, Inc. (SPRY) SEC filings
SPRY SEC filings moved a median of -1.19% by the close. SPRY SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SPRY overview →
57 measured SPRY SEC filing events.
Where these SPRY SEC filings landedvs 57 measured SPRY SEC filing reactions
| Middle 50% of SPRY SEC filing reactions | -3.89% to +1.53% |
|---|---|
| Median reaction (to close) | -1.19% |
| Measured reactions | 57 |
Point-in-time · zero look-ahead
Half of the 57 SPRY SEC filing events with a measured close landed between -3.89% and +1.53%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ARS Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +7.84% | +10.78% | |
| Form 8-K ARS Pharmaceuticals, For: Aug 13 | SEC filing · Form 8-K | +7.84% | +10.78% | |
| Form 8-K ARS Pharmaceuticals, For: Jul 15 | SEC filing · Form 8-K | +0.75% | -8.00% | |
| Form 8-K ARS Pharmaceuticals, For: Jul 06 | SEC filing · Form 8-K | +2.83% | +6.58% | |
| Form 8-K ARS Pharmaceuticals, For: Jun 24 | SEC filing · Form 8-K | +3.08% | +7.15% | |
| Form 10-Q ARS Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -0.81% | +0.34% | |
| Form 8-K ARS Pharmaceuticals, For: May 15 | SEC filing · Form 8-K | -0.81% | +0.34% | |
| Form 8-K ARS Pharmaceuticals, For: May 12 | SEC filing · Form 8-K | -0.17% | -7.72% | |
| Form ARS ARS Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.51% | +5.63% | |
| Form DEF 14A ARS Pharmaceuticals, For: Jun 24 | SEC filing · Form DEF | +0.51% | +5.63% | |
| Form DEFA14A ARS Pharmaceuticals, | SEC filing · Form DEFA14A | +0.51% | +5.63% | |
| Form 10-K ARS Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.21% | -3.10% | |
| Form 8-K ARS Pharmaceuticals, For: Mar 09 | SEC filing · Form 8-K | -0.21% | -3.10% | |
| Form S-8 ARS Pharmaceuticals, | SEC filing · Form S-8 | -1.52% | -2.64% | |
| Form 10-Q ARS Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.30% | -11.20% | |
| Form 8-K ARS Pharmaceuticals, For: Nov 10 | SEC filing · Form 8-K | -0.30% | -11.20% | |
| Form 8-K ARS Pharmaceuticals, For: Sep 29 | SEC filing · Form 8-K | +3.99% | +1.62% | |
| Form 8-K ARS Pharmaceuticals, For: Aug 13 | SEC filing · Form 8-K | -1.78% | -4.46% | |
| Form 10-Q ARS Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -11.15% | -4.12% | |
| Form 8-K ARS Pharmaceuticals, For: Aug 13 | SEC filing · Form 8-K | -11.15% | -4.12% | |
| Form 8-K ARS Pharmaceuticals, For: Jun 25 | SEC filing · Form 8-K | +0.94% | +0.06% | |
| Form 10-Q ARS Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +5.87% | -1.30% | |
| Form 8-K ARS Pharmaceuticals, For: May 14 | SEC filing · Form 8-K | +5.87% | -1.30% | |
| Form 8-K ARS Pharmaceuticals, For: May 02 | SEC filing · Form 8-K | +0.51% | -0.89% | |
| Form ARS ARS Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | -0.87% | +1.45% | |
| Form DEF 14A ARS Pharmaceuticals, For: Jun 25 | SEC filing · Form DEF | -0.87% | +1.45% | |
| Form DEFA14A ARS Pharmaceuticals, | SEC filing · Form DEFA14A | -0.87% | +1.45% | |
| Form 10-K ARS Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +8.91% | +16.34% | |
| Form 8-K ARS Pharmaceuticals, For: Mar 20 | SEC filing · Form 8-K | +8.91% | +16.34% | |
| Form S-8 ARS Pharmaceuticals, | SEC filing · Form S-8 | -6.20% | -13.26% | |
| Form 8-K ARS Pharmaceuticals, For: Mar 05 | SEC filing · Form 8-K | +2.03% | -0.28% | |
| Form S-3ASR ARS Pharmaceuticals, | SEC filing · Form S-3ASR | -0.52% | -2.53% | |
| Form 8-K ARS Pharmaceuticals, For: Jan 13 | SEC filing · Form 8-K | -0.48% | -1.23% | |
| Form 10-Q/A ARS Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +1.71% | -5.00% | |
| Form 10-Q ARS Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -5.65% | -12.60% | |
| Form 8-K ARS Pharmaceuticals, For: Nov 13 | SEC filing · Form 8-K | -5.65% | -12.60% | |
| Form 8-K ARS Pharmaceuticals, For: Nov 09 | SEC filing · Form 8-K | +2.60% | -3.15% | |
| Form 8-K ARS Pharmaceuticals, For: Oct 08 | SEC filing · Form 8-K | -0.73% | +1.20% | |
| Form 8-K ARS Pharmaceuticals, For: Sep 17 | SEC filing · Form 8-K | -2.20% | -2.91% | |
| Form 8-K ARS Pharmaceuticals, For: Aug 09 | SEC filing · Form 8-K | +3.80% | -5.24% | |
| Form 10-Q ARS Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +4.34% | -1.19% | |
| Form 8-K ARS Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | +4.34% | -1.19% | |
| Form 8-K ARS Pharmaceuticals, For: Jun 27 | SEC filing · Form 8-K | -2.16% | +2.16% | |
| Form 8-K ARS Pharmaceuticals, For: Jun 28 | SEC filing · Form 8-K | -0.09% | +1.10% | |
| Form 8-K ARS Pharmaceuticals, For: Jun 20 | SEC filing · Form 8-K | +0.91% | +0.00% | |
| Form 8-K ARS Pharmaceuticals, For: May 10 | SEC filing · Form 8-K | -1.01% | -2.13% | |
| Form 10-Q ARS Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.01% | -2.13% | |
| Form 8-K ARS Pharmaceuticals, For: May 09 | SEC filing · Form 8-K | -1.01% | -2.13% | |
| Form ARS ARS Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.59% | +1.53% | |
| Form DEF 14A ARS Pharmaceuticals, For: Jun 20 | SEC filing · Form DEF | +0.59% | +1.53% | |
| Form DEFA14A ARS Pharmaceuticals, | SEC filing · Form DEFA14A | +0.59% | +1.53% | |
| Form 10-K ARS Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.58% | -3.89% | |
| Form 8-K ARS Pharmaceuticals, For: Mar 21 | SEC filing · Form 8-K | -0.58% | -3.89% | |
| Form S-8 ARS Pharmaceuticals, | SEC filing · Form S-8 | -0.58% | -3.89% | |
| Form 8-K ARS Pharmaceuticals, For: Mar 07 | SEC filing · Form 8-K | +0.22% | -0.33% | |
| Form 10-Q ARS Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +6.98% | +4.19% | |
| Form 8-K ARS Pharmaceuticals, For: Nov 09 | SEC filing · Form 8-K | +6.98% | +4.19% |
Keep exploring
More SPRY: earnings → · analyst actions → · SPRY overview →